Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in <i>HER2</i>-Positive Metastatic Breast Cancer
- DOI
- 10.1200/jco.2008.21.6531
- Published
- 2010-02-20
- Container
- Journal of Clinical Oncology
- Publisher
- American Society of Clinical Oncology (ASCO)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1200/jco.2008.21.6531,
title = {Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in <i>HER2</i>-Positive Metastatic Breast Cancer},
author = {Andrew M. Wardley and Xavier Pivot and Flavia Morales-Vasquez and Luis M. Zetina and Maria de Fátima Dias Gaui and Douglas Otero Reyes and Jacek Jassem and Claire Barton and Peter Button and Veronica Hersberger and Antonio Antón Torres},
year = {2010},
journal = {Journal of Clinical Oncology},
doi = {10.1200/jco.2008.21.6531},
url = {https://doi.org/10.1200/jco.2008.21.6531}
}RIS
TY - JOUR TI - Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in <i>HER2</i>-Positive Metastatic Breast Cancer AU - Andrew M. Wardley AU - Xavier Pivot AU - Flavia Morales-Vasquez AU - Luis M. Zetina AU - Maria de Fátima Dias Gaui AU - Douglas Otero Reyes AU - Jacek Jassem AU - Claire Barton AU - Peter Button AU - Veronica Hersberger AU - Antonio Antón Torres PY - 2010 JO - Journal of Clinical Oncology DO - 10.1200/jco.2008.21.6531 UR - https://doi.org/10.1200/jco.2008.21.6531 ER -
APA
Wardley, A. M., Pivot, X., Morales-Vasquez, F., Zetina, L. M., Gaui, M. D. F. D., Reyes, D. O., Jassem, J., Barton, C., Button, P., Hersberger, V., & Torres, A. A. (2010). Randomized Phase II Trial of First-Line Trastuzumab Plus Docetaxel and Capecitabine Compared With Trastuzumab Plus Docetaxel in <i>HER2</i>-Positive Metastatic Breast Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2008.21.6531
Source records
- crossref · retrieved 2026-09-25T06:05:09.677Z